Hemispherx Biopharma, Inc.
Records under this name other than patents Hemispherx Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Hemispherx Biopharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,943,147 | dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,075,878 | Broad spectrum immune and antiviral gene modulation by oral interferon Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,075,877 | Broad spectrum immune and antiviral gene modulation by oral interferon Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,722,874 | Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,315,538 | Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,642,396 | Method of Reducing Antigenic Drift or Reassortment of Viruses in a Host Animal Using Alpha Interferon Formerly held In force · High confidence | In force | High confidence | |
| US 11,813,279 | Compositions for Cancer Therapy and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 7,678,774 | Treating severe acute respiratory syndrome Formerly held Term ended Term ended Mar 22, 2025 · USPTO record | Term ended | Term ended Mar 22, 2025 | USPTO record |
| US 6,130,206 | Treating viral infections associated with chronic fatigue with dsRNA Formerly held Term ended Term ended Oct 10, 2017 · USPTO record | Term ended | Term ended Oct 10, 2017 | USPTO record |
| US 6,630,455 | Methods for inducing mucosal immune responses Lapsed on the fee record Ended Oct 7, 2011 · USPTO record | Lapsed on the fee record | Ended Oct 7, 2011 | USPTO record |